Novozymes A/S (OTCMKTS:NVZMY) Sees Large Decrease in Short Interest

Novozymes A/S (OTCMKTS:NVZMY) was the recipient of a large drop in short interest in March. As of March 13th, there was short interest totaling 405 shares, a drop of 90.9% from the February 26th total of 4,463 shares. Based on an average daily trading volume, of 258,876 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are short sold. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 258,876 shares, the days-to-cover ratio is presently 0.0 days.

Novozymes A/S Stock Performance

Shares of NVZMY traded up $0.45 on Wednesday, reaching $56.70. 19,000 shares of the company’s stock traded hands, compared to its average volume of 97,675. The stock’s 50 day simple moving average is $59.78 and its two-hundred day simple moving average is $61.54. The stock has a market cap of $23.50 billion, a PE ratio of 40.50, a PEG ratio of 0.98 and a beta of 1.11. Novozymes A/S has a 52-week low of $49.90 and a 52-week high of $75.99. The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 0.26.

Novozymes A/S (OTCMKTS:NVZMY) last posted its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.79 by ($0.44). Novozymes A/S had a return on equity of 6.38% and a net margin of 13.96%.The business had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.22 billion. On average, analysts forecast that Novozymes A/S will post 1.82 earnings per share for the current fiscal year.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).